Daniele Xavier Assad

12PUBLICATIONS
60CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Aboriginal and Torres Strait Islander nursingModels of care and place of birth
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 08, 2026
Body Weight Status and Its Association With Patient-Reported Outcomes in Women With Non-Metastatic ER-Positive Breast Cancer Undergoing Adjuvant Endocrine Therapy.

|Mar 06, 2026
Clinical Impact and Clinicopathologic Correlations of Oncotype DX in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Real-World Evidence From a Large Brazilian Cohort (GBECAM 0520).

Leandro Jonata de Carvalho Oliveira, Daniella Castro Araújo, Júlio Antonio Pereira de Araújo

|Jan 30, 2026
Cost-Effectiveness of the Oncotype DX Breast Recurrence Score Test in the Brazilian Private Health Care Sector.

Ivan Zimmermann, Carlos Alberto da Silva Magliano, Leandro Jonata de Carvalho Oliveira

|Jan 23, 2026
Sexual dysfunction in Brazilian women undergoing adjuvant endocrine therapy for breast cancer: prevalence and associated factors.

Daniele Assad-Suzuki, Danielle Laperche-Santos, Heloisa Resende

|Oct 30, 2025
Employment Status Among Brazilian Women With Estrogen Receptor-Positive Nonmetastatic Breast Cancer.

Daniele Assad-Suzuki, Luciana Castro Garcia Landeiro, Danielle Laperche-Santos

|Oct 22, 2025
Budget Impact of the Oncotype DX Test in Early-Stage Breast Cancer for the Brazilian Private Health Care System.

Carlos Alberto da Silva Magliano, Ivan R Zimmermann, Leandro Jonata de Carvalho Oliveira

Pageof 2

Frequent Collaborators

6 joint publications

Andrea Kazumi Shimada

4 joint publications

Yuri Cardoso Rodrigues Beckedorff Bittencourt

4 joint publications

Danielle Laperche-Santos

3 joint publications

Angélica Nogueira-Rodrigues